The Challenge of Short-Term Relief with Hyaluronic Acid Injections
Hyaluronic acid injections work by supplementing the natural fluid in the knee joint, temporarily improving lubrication. This can reduce pain and improve movement for people with OA. As Strauss and colleagues (2009) explain, HA has "anti-inflammatory, anabolic, and chondroprotective" effects, meaning it not only soothes pain but can also support joint health.
Despite these benefits, the relief from HA injections tends to be temporary — often lasting just a few weeks to several months. What’s more, patient experiences can vary widely. Some find substantial benefit, while others notice only slight improvements. Another downside is the need for several injection sessions, typically three to five over a few weeks, which can feel inconvenient and disruptive.
Healthcare guidelines recognise these challenges. HA injections alone may not be enough for those with advanced OA or highly active lifestyles seeking longer-term management. This situation highlights the need for new injectable treatments that are more reliable and convenient — offering consistent relief that lasts.
Arthrosamid: A Modern Approach to Managing Knee Osteoarthritis
Arthrosamid takes a different approach. It’s a hydrogel-based injection that interacts closely with the lining of the joint, forming a stable cushion. Unlike HA, which mainly top-ups the joint fluid, Arthrosamid integrates with the synovial lining, which may help it last longer and provide ongoing mechanical support.
One of the biggest advantages is convenience: Arthrosamid usually requires just a single injection session. This reduces clinic visits and makes the treatment easier to fit into busy lives. Early research and clinical experience show that Arthrosamid can provide longer-lasting symptom relief and improved knee function compared to traditional HA injections. Recent studies confirm that "Arthrosamid® has been known to be safe and efficacious in knee osteoarthritis (OA) patients."
A 24-month study also found that Arthrosamid improved knee symptoms particularly well in "older, non-diabetic patients with lower KL grades," hinting at which patients stand to benefit most. However, it’s important to remember that treatment should always be personalised — what works for one patient may not suit another. As research notes, “the literature surrounding which patients would incur the most benefit from Arthrosamid is limited,” so ongoing studies and clinical judgement remain key.
Free non-medical discussion
Not sure what to do next?
Information only · No medical advice or diagnosis.
Who Benefits Most? Comparing Arthrosamid and Hyaluronic Acid
When weighing up Arthrosamid and HA injections, a few clear differences emerge in terms of how long relief lasts, how convenient the treatments are, and how consistent the results tend to be.
HA has a proven safety record and can be used repeatedly, but its effects are usually short-lived, meaning patients need multiple injections over time. This ongoing treatment schedule can disrupt daily routines. Arthrosamid’s hydrogel technology aims to break this pattern by offering extended relief with a single injection — a clear boost in convenience.
Evidence is growing to help doctors decide who might gain the most from Arthrosamid. One study highlights that the odds of meaningful improvement increase for patients who are older, have milder OA, are non-diabetic, and have both knees affected rather than just one. Meanwhile, those with mild or intermittent symptoms may still do well with conventional HA injections.
Professor Paul Lee emphasises that selecting the right treatment comes down to careful evaluation of each patient’s condition and lifestyle. MSK Doctors provide the professional support to help patients navigate these choices confidently and access the most suitable therapies.
The Road Ahead: Responsible Innovation and Putting Patients First
The world of viscosupplementation is evolving. Treatments like Arthrosamid are pushing the boundaries, encouraging us to think beyond short-term symptom relief towards more durable, long-term OA management.
That progress relies on ongoing research, clear patient education, and a commitment to using evidence-based treatments suited to individual needs. As one recent two-year study concluded, “further studies are warranted to validate efficacy, refine patient selection, and evaluate long-term impact.”
With experts like Professor Paul Lee and compassionate teams such as MSK Doctors offering multidisciplinary care, patients are supported safely and effectively as new therapies enter clinical practice. This approach ensures innovation is always centred around delivering real, lasting benefits.
For personalised advice and treatment options, patients should consult qualified healthcare professionals who can tailor recommendations according to their unique situation.
By comparing Arthrosamid and hyaluronic acid injections, it’s clear that advances are happening — offering hope for more lasting, convenient relief for those living with knee OA. These improved options empower clinicians and patients alike, helping to enhance quality of life in the face of this common joint condition.
References
- Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., & Lee, P. Y. (2025). The impact of patient factors on the minimal clinically important difference of Arthrosamid polyacrylamide hydrogel injection for knee osteoarthritis: A cohort study. Osteoarthritis and Cartilage. https://doi.org/10.1016/j.joca.2025.02.648
- Gao, H. C. K., Akhtar, M., Creedon, C., Nar, Ö. O., Verma, T., & Lee, P. Y. F. (2025). Polyacrylamide hydrogel injections in knee osteoarthritis: A PROMs-based 24 month cohort study. Journal of Clinical Orthopaedics and Trauma. https://doi.org/10.1016/j.jcot.2025.103136
- Strauss, E. J., Hart, J., Miller, M. D., Altman, R. D., & Rosen, J. (2009). Hyaluronic acid viscosupplementation and osteoarthritis. The American Journal of Sports Medicine, 37(8), 1636–1644. https://doi.org/10.1177/0363546508326984
Frequently Asked Questions
- Arthrosamid is a hydrogel-based injection that offers longer-lasting mechanical support with usually a single session. In contrast, hyaluronic acid injections typically provide only short-term relief and often require multiple sessions, making Arthrosamid a more convenient option.
- MSK Doctors are renowned for their expertise in innovative joint treatments. With specialists like Professor Paul Lee, patients benefit from advanced techniques, thorough evaluation, and a multidisciplinary approach, guiding them confidently toward the most appropriate personalised care options.
- Professor Paul Lee is a Cartilage Expert, the Regional Surgical Ambassador, and an Advisor for the Royal College of Surgeons of Edinburgh. His recognised leadership ensures patients receive state-of-the-art management and professional guidance in complex joint and cartilage issues.
- Evidence indicates that older patients, those with milder osteoarthritis, non-diabetics, and individuals with both knees affected may achieve better outcomes from Arthrosamid injections. However, thorough assessment by experts like Professor Lee ensures optimal personalised therapy.
- MSK Doctors, led by specialists like Professor Lee, emphasise evidence-based innovation, education, and multidisciplinary care. This approach ensures that patients benefit from ongoing advances in osteoarthritis therapies, always prioritising safety and long-term quality of life.
Legal & Medical Disclaimer
This article is written by an independent contributor and reflects their own views and experience, not necessarily those of Lincolnshire Hip Clinic. It is provided for general information and education only and does not constitute medical advice, diagnosis, or treatment.
Always seek personalised advice from a qualified healthcare professional before making decisions about your health. Lincolnshire Hip Clinic accepts no responsibility for errors, omissions, third-party content, or any loss, damage, or injury arising from reliance on this material.
If you believe this article contains inaccurate or infringing content, please contact us at [email protected].
